Literature DB >> 20625025

A single-question screening test for drug use in primary care.

Peter C Smith1, Susan M Schmidt, Donald Allensworth-Davies, Richard Saitz.   

Abstract

BACKGROUND: Drug use (illicit drug use and nonmedical use of prescription drugs) is common but underrecognized in primary care settings. We validated a single-question screening test for drug use and drug use disorders in primary care.
METHODS: Adult patients recruited from primary care waiting rooms were asked the single screening question, "How many times in the past year have you used an illegal drug or used a prescription medication for nonmedical reasons?" A response of at least 1 time was considered positive for drug use. They were also asked the 10-item Drug Abuse Screening Test (DAST-10). The reference standard was the presence or absence of current (past year) drug use or a drug use disorder (abuse or dependence) as determined by a standardized diagnostic interview. Drug use was also determined by oral fluid testing for common drugs of abuse.
RESULTS: Of 394 eligible primary care patients, 286 (73%) completed the interview. The single screening question was 100% sensitive (95% confidence interval [CI], 90.6%-100%) and 73.5% specific (95% CI, 67.7%-78.6%) for the detection of a drug use disorder. It was less sensitive for the detection of self-reported current drug use (92.9%; 95% CI, 86.1%-96.5%) and drug use detected by oral fluid testing or self-report (81.8%; 95% CI, 72.5%-88.5%). Test characteristics were similar to those of the DAST-10 and were affected very little by participant demographic characteristics.
CONCLUSION: The single screening question accurately identified drug use in this sample of primary care patients, supporting the usefulness of this brief screen in primary care.

Entities:  

Mesh:

Year:  2010        PMID: 20625025      PMCID: PMC2911954          DOI: 10.1001/archinternmed.2010.140

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

1.  Screening for drug and alcohol abuse among older adults using a modified version of the CAGE.

Authors:  C H Hinkin; S A Castellon; E Dickson-Fuhrman; G Daum; J Jaffe; L Jarvik
Journal:  Am J Addict       Date:  2001

2.  Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.

Authors:  R S Niedbala; K W Kardos; D F Fritch; S Kardos; T Fries; J Waga; J Robb; E J Cone
Journal:  J Anal Toxicol       Date:  2001 Jul-Aug       Impact factor: 3.367

3.  Primary care: is there enough time for prevention?

Authors:  Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

4.  Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.

Authors:  Edward J Cone; Lance Presley; Michael Lehrer; William Seiter; Melissa Smith; Keith W Kardos; Dean Fritch; Sal Salamone; R Sam Niedbala
Journal:  J Anal Toxicol       Date:  2002 Nov-Dec       Impact factor: 3.367

5.  Laboratory analysis of remotely collected oral fluid specimens for opiates by immunoassay.

Authors:  R S Niedbala; K Kardos; J Waga; D Fritch; L Yeager; S Doddamane; E Schoener
Journal:  J Anal Toxicol       Date:  2001 Jul-Aug       Impact factor: 3.367

6.  Immunoassay for detection of cocaine/metabolites in oral fluids.

Authors:  R S Niedbala; K Kardos; T Fries; A Cannon; A Davis
Journal:  J Anal Toxicol       Date:  2001 Jan-Feb       Impact factor: 3.367

7.  The RAFFT as a screening tool for adult substance use disorders.

Authors:  Leo Bastiaens; Kathleen Riccardi; Duru Sakhrani
Journal:  Am J Drug Alcohol Abuse       Date:  2002-11       Impact factor: 3.829

8.  The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.

Authors: 
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

9.  Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences.

Authors:  Kimberly A Blanchard; Jon Morgenstern; Thomas J Morgan; Erich W Lobouvie; Donald A Bux
Journal:  Psychol Addict Behav       Date:  2003-12

10.  Primary care validation of a single-question alcohol screening test.

Authors:  Peter C Smith; Susan M Schmidt; Donald Allensworth-Davies; Richard Saitz
Journal:  J Gen Intern Med       Date:  2009-02-27       Impact factor: 5.128

View more
  154 in total

1.  Update in pain medicine.

Authors:  Daniel P Alford; Erin E Krebs; Ian A Chen; Christina Nicolaidis; Matthew J Bair; Jane Liebschutz
Journal:  J Gen Intern Med       Date:  2010-07-15       Impact factor: 5.128

2.  The Evolution of Aging With Pride-National Health, Aging, and Sexuality/Gender Study: Illuminating the Iridescent Life Course of LGBTQ Adults Aged 80 Years and Older in the United States.

Authors:  Karen Fredriksen Goldsen; Hyun-Jun Kim; Hyunzee Jung; Jayn Goldsen
Journal:  Int J Aging Hum Dev       Date:  2019-04-08

3.  Discussing Drug Use With Health Care Providers Is Associated With Perceived Need and Receipt of Drug Treatment Among Adults in the United States: We Need to Talk.

Authors:  Pia M Mauro; Hillary Samples; Kathryn S Klein; Silvia S Martins
Journal:  Med Care       Date:  2020-07       Impact factor: 2.983

4.  Trajectories of drug use and mortality outcomes among adults followed over 18 years.

Authors:  Stefan G Kertesz; Yulia Khodneva; Joshua Richman; Jalie A Tucker; Monika M Safford; Bobby Jones; Joseph Schumacher; Mark J Pletcher
Journal:  J Gen Intern Med       Date:  2012-01-25       Impact factor: 5.128

5.  Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy.

Authors:  Victoria H Coleman-Cowger; Emmanuel A Oga; Erica N Peters; Katrina Mark
Journal:  Neurotoxicol Teratol       Date:  2018-06-05       Impact factor: 3.763

6.  Improving urban African Americans' blood pressure control through multi-level interventions in the Achieving Blood Pressure Control Together (ACT) study: a randomized clinical trial.

Authors:  Patti L Ephraim; Felicia Hill-Briggs; Debra L Roter; Lee R Bone; Jennifer L Wolff; LaPricia Lewis-Boyer; David M Levine; Hanan J Aboumatar; Lisa A Cooper; Stephanie J Fitzpatrick; Kimberly A Gudzune; Michael C Albert; Dwyan Monroe; Michelle Simmons; Debra Hickman; Leon Purnell; Annette Fisher; Richard Matens; Gary J Noronha; Peter J Fagan; Hema C Ramamurthi; Jessica M Ameling; Jeanne Charlston; Tanyka S Sam; Kathryn A Carson; Nae-Yuh Wang; Deidra C Crews; Raquel C Greer; Valerie Sneed; Sarah J Flynn; Nicole DePasquale; L Ebony Boulware
Journal:  Contemp Clin Trials       Date:  2014-06-21       Impact factor: 2.226

7.  How patients understand the term "nonmedical use" of prescription drugs: insights from cognitive interviews.

Authors:  Jennifer McNeely; Perry N Halkitis; Ariana Horton; Rubina Khan; Marc N Gourevitch
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

8.  Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.

Authors:  Onyema Ogbuagu; Brandon D L Marshall; Perry Tiberio; Adedotun Ogunbajo; Lydia Barakat; Madeline Montgomery; Alexi Almonte; Tyler Wray; Emily C Williams; E Jennifer Edelman; Philip A Chan
Journal:  AIDS Behav       Date:  2019-01

9.  Real-world implementation and outcomes of health behavior and mental health assessment.

Authors:  Hector P Rodriguez; Beth A Glenn; Tanya T Olmos; Alex H Krist; Stephanie L Shimada; Rodger Kessler; Suzanne Heurtin-Roberts; Roshan Bastani
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

10.  Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.

Authors:  Peter Roy-Byrne; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Richard Ries; Dennis Donovan; Imara I West; Charles Maynard; David C Atkins; Meredith C Graves; Jutta M Joesch; Gary A Zarkin
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.